Monday, May 4, 2026

Coronavirus antibodies last at least three months after infection, University of Toronto study finds

Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published in Science Immunology.

Online job advertisements continue to bounce back

Looking for a job? The COVID-19 impact on the Australian labour market has been daunting and dispiriting, but as we round out the year, online job vacancies are increasing.

Screen Work 2020 – Future skills and innovation for the Screen Sector in the...

Screen Work 2020 is the first comprehensive survey of workforce, training and education needs for Film, Television, Animation, Games, VFX and Post-Production in the Cardiff City Region.

Significant drop in Australians who will get COVID jab

There has been a substantial increase in COVID-19 vaccine resistance and hesitancy among Australians, according to new analysis from The Australian National University.

Vaccination by inhalation

Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.

First step to curb COVID vaccine misinformation is finding out who is most vulnerable

The success of Australia’s COVID-19 vaccine rollout will depend on everyone’s willingness to receive it. But experts have warned vaccine misinformation online puts Australia’s communities at risk...

It will be a long, long wait for Covid herd immunity

Opinion: The ongoing crisis over the Covid-positive person who visited Wellington from Sydney raises questions about the Government’s zero Covid stance, writes Professor Ananish Chaudhuri.

Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

Recruitment commences for Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines

Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines.

Surgical masks as good as N95 masks for health-care workers providing routine COVID-19 care

Surgical masks are not inferior to N95 masks for preventing the spread of COVID-19 to health-care workers, says a study led by McMaster University researchers.
- Advertisement -